The United States Food and Drug Administration (FDA) issued on Saturday the emergency use authorization for a coronavirus antigen test, aiming to enable faster detecting of COVID-19 nationwide.
The new testing method is designed to detect fragments of proteins on or within the virus by testing samples, showing test results in minutes.
On Friday, the FDA authorized the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing.